Modulation of angiogenesis with siRNA inhibitors for novel therapeutics

scientific article

Modulation of angiogenesis with siRNA inhibitors for novel therapeutics is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.MOLMED.2005.01.005
P698PubMed publication ID15760768

P2093author name stringPatrick Y Lu
Frank Y Xie
Martin C Woodle
P2860cites workTACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cellsQ24301702
TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptorQ24302424
Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinasesQ24311877
Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASCQ24316380
Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosisQ24329055
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticleQ24560011
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesisQ28140740
PINCH-1 Is an Obligate Partner of Integrin-linked Kinase (ILK) Functioning in Cell Shape Modulation, Motility, and SurvivalQ28208706
Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWVQ28247378
The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migrationQ28250994
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitroQ28259748
Expression profiling reveals off-target gene regulation by RNAiQ29615965
Activation of the interferon system by short-interfering RNAsQ29620341
Basement membranes: structure, assembly and role in tumour angiogenesisQ29622882
DIP (mDia interacting protein) is a key molecule regulating Rho and Rac in a Src-dependent mannerQ30555216
Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.Q30944070
Clinical translation of angiogenesis inhibitorsQ34152769
Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.Q34206478
PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factorQ34227481
ILKAP regulates ILK signaling and inhibits anchorage-independent growthQ34301995
Lymphangiogenesis and cancer metastasisQ34770288
Gene silencing in mammals by small interfering RNAsQ34931992
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitisQ35103511
siRNA-mediated antitumorigenesis for drug target validation and therapeutics.Q35180667
Pharmaceutical prospects for RNA interference.Q35675699
Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration.Q38347930
CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cellsQ38350055
Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.Q39887642
Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirusQ40534160
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosisQ40541706
Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery systemQ40544030
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeuticsQ40554467
RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferationQ40606546
The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stressQ40615412
Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expressionQ40615471
RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells.Q40624379
Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cellsQ40653427
Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cellsQ40656821
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitmentQ40725945
Absence of adhesion triggers differential FAK and SAPKp38 signals in SW620 human colon cancer cells that may inhibit adhesiveness and lead to cell deathQ43924853
Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3.Q44043660
RNA interference may be more potent than antisense RNA in human cancer cell linesQ44287642
Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikisQ44502162
The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engagedQ44526089
Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitroQ44564083
Use of RNA interference to inhibit integrin (alpha6beta4)-mediated invasion and migration of breast carcinoma cellsQ44642910
Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and proteinQ44673718
Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signalingQ44709429
Regulation of tumor angiogenesis by integrin-linked kinase (ILK).Q44746334
Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.Q44802905
Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cellsQ44814597
c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix componentsQ44816472
Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritisQ44827452
IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.Q44951935
Cyclic strain-induced endothelial MMP-2: role in vascular smooth muscle cell migrationQ44953572
VEGF gene polymorphisms and susceptibility to rheumatoid arthritisQ47301767
Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cellsQ47364895
Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathwayQ47400542
siRNA agents inhibit oncogene expression and attenuate human tumor cell growthQ47435082
Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.Q47808941
Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.Q47852768
Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritisQ47941172
Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis.Q51051039
SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.Q53923164
Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma CellsQ63432724
Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathwayQ73806599
Lack of interferon response in animals to naked siRNAsQ81042789
P433issue3
P304page(s)104-113
P577publication date2005-03-01
P1433published inTrends in Molecular MedicineQ15265842
P1476titleModulation of angiogenesis with siRNA inhibitors for novel therapeutics
P478volume11

Reverse relations

cites work (P2860)
Q33329034Analysis of siRNA specificity on targets with double-nucleotide mismatches
Q92354274Antiangiogenic properties of nanoparticles: a systematic review
Q39564323Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression
Q37120441Delivering small interfering RNA for novel therapeutics
Q34149828Efficient and targeted delivery of siRNA in vivo
Q37589238Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells
Q36804396Genetic association meets RNA interference: large-scale genomic screens for causation and mechanism of complex diseases
Q44791097Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of Ras.
Q36396538Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
Q36226774In vivo application of RNA interference: from functional genomics to therapeutics
Q35747541Inhibition of human immunodeficiency virus replication by cell membrane-crossing oligomers
Q37855818Leveraging therapeutic potential of multi-targeted siRNA inhibitors
Q38772275Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis
Q37481329RNA interference as an anticancer therapy: a patent perspective
Q36840109RNA interference-mediated gene silencing in murine T cells: in vitro and in vivo validation of proinflammatory target genes
Q34225712RNA interference-mediated gene silencing of vascular endothelial growth factor in colon cancer cells
Q36311494RNA interference: ready to silence cancer?
Q36199753Silence of the transcripts: RNA interference in medicine
Q36015790Silencing of Rac1 expression via RNA interference inhibits retinal neovascularization in rats.
Q36237868The therapeutic potential of RNA interference
Q88965519Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
Q38242397Therapeutic potential of siRNA and DNAzymes in cancer.